Journal
JOURNAL OF ALZHEIMERS DISEASE
Volume 51, Issue 3, Pages 677-682Publisher
IOS PRESS
DOI: 10.3233/JAD-151066
Keywords
Alzheimer's disease; APPswe/PS1dE9; epilepsy; fluoxetine; premature death; seizure
Categories
Funding
- Internationale Stichting Alzheimer Onderzoek (ISAO) [07551, 11532]
Ask authors/readers for more resources
Treatment of Alzheimer's disease (AD) patients with the antidepressant fluoxetine is known to improve memory and cognitive function. However, the mechanisms underlying these effects are largely unknown. To unravel these mechanisms, we aimed to treat APPswe/PS1dE9 mice with fluoxetine. Unexpectedly, with time, an increased number of animals displayed seizure behavior and died. Although spontaneous behavioral seizures have been reported previously in this mouse model, the observation of seizures and death consequential to fluoxetine treatment is new. Our results warrant further research on the underlying mechanisms as this may refine the treatment of AD patients.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available